Baker Brothers Advisors - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 85 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2013. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$526,000
-44.6%
2,021,728
+313.4%
0.01%
-25.0%
Q1 2015$949,000
-28.4%
489,053
-2.2%
0.01%
-42.9%
Q4 2014$1,325,000
-12.0%
500,0000.0%0.01%
-26.3%
Q3 2014$1,505,000
-26.4%
500,0000.0%0.02%
-24.0%
Q2 2014$2,045,000
-5.1%
500,0000.0%0.02%
-7.4%
Q1 2014$2,155,000
-17.7%
500,0000.0%0.03%
-27.0%
Q4 2013$2,620,000
-17.0%
500,0000.0%0.04%
-17.8%
Q3 2013$3,155,000
-54.8%
500,000
-64.3%
0.04%
-67.4%
Q2 2013$6,981,0001,399,0400.14%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders